Drug · DIN 02350815
MORPHINE SR
No: no longer authorized
The company stopped selling it and its DIN was cancelled. A cancellation is most often a business decision; the record does not say why.
Status Cancelled Post Market since December 23, 2020; first marketed March 1, 2011.
- Drug Identification Number (DIN)
- 02350815
- Company (DIN owner)
- Sanis Health Inc.Brampton, Ontario, Canada
- Schedule
- Narcotics (CDSA I)
- Dosage form
- Tablet (Extended-Release)
- Route
- Oral
- Therapeutic class (ATC)
- Morphine N02AA01
- Class
- Human
- Record last updated
- June 23, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| MORPHINE SULFATE | 15 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- October 16, 2014: NOC 16183Abbreviated New Drug Submission (ANDS) · Licensing agreement beetween two companies
- May 6, 2010: NOC 11354Abbreviated New Drug Submission (ANDS) · New manufacturer and product name
Other DINs named MORPHINE SR
- DIN 02350890 · Cancelled Post Market
- DIN 02350912 · Cancelled Post Market
- DIN 02350920 · Cancelled Post Market
- DIN 02350947 · Cancelled Post Market